Semaglutide, optimal therapy for type 2 diabetes with few side effects: Study

Press/Media

Period1 Jun 2022

Media coverage

1

Media coverage

  • TitleSemaglutide, optimal therapy for type 2 diabetes with few side effects: Study
    Media name/outletMedical Dialogues
    Country/TerritoryIndia
    Date1/06/22
    PersonsMostafa Hassan